Barclays »

Contineum Therapeutics shares owned by Barclays

Quarter-by-quarter ownership of Contineum Therapeutics (CTNM) shares owned by Barclays from 13F filings

Historical chart of Barclays investment in Contineum Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Contineum Therapeutics held by Barclays consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Contineum Therapeutics by Barclays

Quarter filed Position value Share count Share price at filing
2024-09-30 $158k 8.3k 19.02
2024-06-30 $42k 2.4k 17.62